Blood Pressure Variability and Subclinical Brain Disease

Elevated blood pressure variability was associated with a wide range of subclinical structural changes in the brain. These structural changes could be the mechanisms explaining a higher incidence of dementia and stroke.

Efectos de la radiación cerebral en Cardiólogos Intervencionistas

This study included 2348 participants age ≥55 years in a prospective cohort. Blood pressure was measured in each visit since 1990, and since 2005 all visits included a magnetic resonance imaging scan.

Authors first assessed the absolute difference in blood pressure over two sequential visits for both systolic and diastolic blood pressure.

Then, they assessed the direction of the variation and associated it with the magnetic resonance imaging scans through a multivariate analysis. Small vessel disease, brain tissue volumes, and white matter microstructural integrity were all taken into account.

Higher blood pressure variation (top vs. bottom tertiles) was associated with more severe white matter hyperintensities (odds ratio [OR]: 1.32), lacunes (OR: 1.25), and microbleeds (OR: 1.16).


Read also: Cerebrovascular Events After TAVR May Be Especially Serious.


Similarly, such variation was associated with smaller total brain volume and worse white matter microstructural integrity.

Such brain damage was observed with both large rises and falls in blood pressure.

Conclusion

Elevated blood pressure variability was associated with a large number of structural brain changes observed through magnetic resonance imaging. These changes, which are subclinical at first, could be the mechanisms that afterwards increase the incidence of dementia and stroke.

Original Title: Blood Pressure Variation and Subclinical Brain Disease.

Reference: Yuan Ma et al. J Am Coll Cardiol 2020;75:2387–99.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....

Chronic Thromboembolic Pulmonary Hypertension: Treatment Outcomes According to a Worldwide Registry

Chronic thromboembolic pulmonary hypertension (CTEPH) is a highly limiting condition that, despite its moderate incidence, significantly impacts patient prognosis and quality of life. The...

Contemporary Outcomes of Acute Limb Ischemia Endovascular Revascularization

Acute limb ischemia (ALI) is a vascular emergency with high mortality rate. It has been defined as a sudden occlusion of limb perfusion compromising...

TCT 2024 | SIRONA: Randomized Study Comparing Sirolimus-Coated vs Paclitaxel-Coated Balloon Angioplasty in Femoropopliteal Disease

This prospective, randomized, multicenter, investigator-initiated non-inferiority study compared the use of sirolimus-coated balloon (MagicTouch) vs paclitaxel-coated balloon in endovascular treatment.  The primary objective was to...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Severe Tricuspid Regurgitation: Surgical vs. Transcatheter Edge-to-Edge Repair

While highly prevalent, tricuspid regurgitation is a notably undertreated valvulopathy. Its progression has been associated with higher mortality and significant disability. According to the...

ACCESS-TAVI: Comparing Post TAVR Vascular Closure Devices

Transcatheter aortic valve replacement (TAVR) is a well-established option to treat elderly patients with severe symptomatic aortic valve stenosis. Technical advances and device development...

Endovascular Treatment of Iliofemoral Disease for the Improvement of Heart Failure with Preserved Ejection Fraction

Peripheral artery disease (PAD) is a significant risk factor in the development of difficult-to-treat conditions, such as heart failure with preserved ejection fraction (HFpEF)....